• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Zentek Ltd.

    3/21/25 4:38:27 PM ET
    $ZTEK
    Major Chemicals
    Industrials
    Get the next $ZTEK alert in real time by email
    6-K 1 form6k.htm FORM 6-K Zentek Ltd.: Form 6-K - Filed by newsfilecorp.com

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    OF THE SECURITIES EXCHANGE ACT OF 1934

    For the month of March 2025

    Commission File Number: 001-41310

    ZENTEK LTD.

    (Registrant)

    24 Corporate Court

    Guelph, Ontario N1G 5G5 Canada

    (Address of Principal Executive Offices)

    Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F  ☐            Form 40-F  ☒

    Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

    Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      ZENTEK LTD.
      (Registrant)
         
    Date: March 21, 2025 By /s/ Wendy Ford
        Wendy Ford
        Chief Financial Officer


    EXHIBIT INDEX

    Exhibit Description of Exhibit
       
    99.1 Press Release dated March 21, 2025 - Zentek Announces Results of Canada Revenue Agency Audit


    Get the next $ZTEK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZTEK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZTEK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zentek Provides Update on ZenGUARD(TM) Enhanced Air Filters for the Canadian Market

      GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on the launch of ZenGUARD™ Enhanced Air Filters in the Canadian Market.The Company is prioritizing the completion of all required documentation to support the manufacture and sale of ZenGUARD™ Enhanced Air Filters under its existing medical device establishment licence ("MDEL") alongside ZenGUARD™ Surgical Masks. This documentation will be completed in compliance with Canadian Medical Device Regulations (MDR) and ISO 13485:2016 Quality Management System for medical devices.The Com

      1/17/25 8:00:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity

      GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a preliminary five-nines purity of 99.9991% directly from a larger Albany graphite deposit flotation concentrate sample utilizing an operational pilot-scale fluidized bed reactor (FBR).HighlightsUltra-high purity "five nines" 99.9991 wt.% from a platinum crucible Loss on Ignition (LOI) analysisPurification was performed utilizing an existing pilot-scale FBR directly on a ~950 g sample of the Albany flotati

      1/8/25 9:10:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Provides Update on International Opportunities

      GUELPH, ON / ACCESSWIRE / December 12, 2024 / Zentek Ltd. (" Zentek "or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Memorandum of Understanding ("MOU") with Al-Ramez International Group - through Saudi Excellence Holding Company - establishing a strategic partnership to drive innovation and commercialization in advanced technologies across the Kingdom of Saudi Arabia ("KSA") and the Middle East and North Africa ("MENA") region on November 14 th 2024.Memorandum of Understanding OverviewThe MOU outlines a collaborative framework where Zentek intends to contribute intellectual property, product licensing, and researc

      12/12/24 8:30:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials

    $ZTEK
    SEC Filings

    See more
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      5/16/25 9:50:10 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      4/23/25 10:18:41 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      4/17/25 4:35:03 PM ET
      $ZTEK
      Major Chemicals
      Industrials

    $ZTEK
    Leadership Updates

    Live Leadership Updates

    See more
    • Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology

      GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved key challenges for manufacturing and these High-Binding Affinity (HBA) aptamers are now produced with approximately a 95% yield. A key roadblock of translating a promising lead candidate (lab-scale therapeutic) into a commercial product is cost-effective and high-purity manu

      11/15/23 8:15:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology

      GUELPH, ON / ACCESSWIRE / October 5, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the rapid-detection platform and the recent aptamer-based platform technology developed by Dr. Yingfu Li and his team that is showing promise as a therapeutic through preclinical studies being conducted by Dr. Matthew Miller and his team. This new entity has been launched as a vehicle to accel

      10/5/23 7:15:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Announces Appointment of New Director of Investor Relations

      GUELPH, ON / ACCESSWIRE / January 12, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations.Mr. Swergold earned a Bachelor of Arts in Political Science from Columbia University in the City of New York, and a Juris Doctor degree from Emory University School of Law. After practicing law and serving as a research analyst at two investment banks, Mr. Swergold was a Senior Analyst and Portfolio Manager at various hedge funds, focusing on technology and macroeconomic investing."Mitch's experience investing in technology companies, from early to la

      1/12/23 8:00:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials